115 related articles for article (PubMed ID: 3427262)
1. Experimental studies on pathogenesis and progression of uremic neuropathy in rats. II. Is plasma myoinositol a uremic neurotoxin?
Onishi S; Kawasaki T; Hamada K
Bull Osaka Med Sch; 1986 Oct; 32(2):66-72. PubMed ID: 3427262
[No Abstract] [Full Text] [Related]
2. Experimental studies on pathogenesis and progression of uremic neuropathy in rats. I. Development of chronic renal failure in rats.
Onishi S; Okada S; Takasaki N
Bull Osaka Med Sch; 1986 Oct; 32(2):60-5. PubMed ID: 3427261
[No Abstract] [Full Text] [Related]
3. Myoinositol--a uremic neurotoxin?
Blumberg A; Esslen E; Bürgi W
Nephron; 1978; 21(4):186-91. PubMed ID: 683404
[TBL] [Abstract][Full Text] [Related]
4. Axoplasmic electrolyte contents measured by X-ray microanalysis in experimental uremic neuropathy.
Shibahara N; Okada S; Onishi S; Hamada K; Takasaki N; Miyazaki S; Nakagaki I; Sasaki S
Nihon Jinzo Gakkai Shi; 1990 Aug; 32(8):885-92. PubMed ID: 2174479
[TBL] [Abstract][Full Text] [Related]
5. Blood levels of middle molecules and their effects on motor nerve conduction velocity.
Botella J; Gea T; Sanz-Guajardo D; Criado M; Torres MT; Guardiola J
Artif Organs; 1981; 4 Suppl():151-5. PubMed ID: 7295082
[TBL] [Abstract][Full Text] [Related]
6. Plasma-myoinositol concentrations in uraemic neuropathy.
Reznek RH; Salway JG; Thomas PK
Lancet; 1977 Mar; 1(8013):675-6. PubMed ID: 66475
[TBL] [Abstract][Full Text] [Related]
7. Raised plasma-myoinositol levels in uraemia and experimental neuropathy.
Clements RS; DeJesus PV; Winegrad AI
Lancet; 1973 May; 1(7813):1137-41. PubMed ID: 4123536
[No Abstract] [Full Text] [Related]
8. [Uremic polyneuropathy. Case studies].
Fierro B; Fradà G; Li Vecchi M; Raimondo D
Arch Sci Med (Torino); 1981; 138(4):609-14. PubMed ID: 7340740
[No Abstract] [Full Text] [Related]
9. Relationship between plasma concentration of middle molecular weight fraction b, motor nerve conduction velocity, and plasma creatinine in experimental chronic renal failure rats.
Boudet J; Man NK; Cueille G; Legrain Y; Funck-Brentano JL
Artif Organs; 1981; 4 Suppl():115-8. PubMed ID: 7295077
[No Abstract] [Full Text] [Related]
10. Neurotoxicity of parathyroid hormone in uremia.
Massry SG
Kidney Int Suppl; 1985 Dec; 17():S5-11. PubMed ID: 3912589
[No Abstract] [Full Text] [Related]
11. [Study of nerve conduction velocity in uremic neuropathy].
Parisen Toldin P; Pisani E; D'Andrea G; Lagreca G; Ferro Milone F
Riv Neurobiol; 1976; 22(1-2):45-6. PubMed ID: 1052935
[No Abstract] [Full Text] [Related]
12. Uremic neuropathy: clinical features and new pathophysiological insights.
Krishnan AV; Kiernan MC
Muscle Nerve; 2007 Mar; 35(3):273-90. PubMed ID: 17195171
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between serum myo-inositol and peripheral neuropathy in patients with chronic renal failure].
Kuzuhara K; Kaniu H; Tsuji H; Furukawa K; Miura M; Hara S; Suzuki Y; Nihei H; Akagi K; Uchigata M
Nihon Jinzo Gakkai Shi; 1986 Jun; 28(6):739-47. PubMed ID: 3022045
[No Abstract] [Full Text] [Related]
14. [Influence of erythropoietin produced in vitro on experimental uremic anemia].
Hu R
Zhonghua Yi Xue Za Zhi; 1990 Sep; 70(9):522-4. PubMed ID: 1964859
[No Abstract] [Full Text] [Related]
15. Does uremic enterocolitis exist? A morphological and functional investigation of rat intestine in chronic renal insufficiency.
Gabbert H; Wagner R; Höhn P; Kern O; Wanitschke R
Virchows Arch B Cell Pathol Incl Mol Pathol; 1981; 37(3):285-96. PubMed ID: 6117973
[TBL] [Abstract][Full Text] [Related]
16. [Uremic neuropathies. Comparative study of the velocity of motor and nerve conduction during predialysis, hemodialysis and postransplantation periods].
Fernández González F
Arch Neurobiol (Madr); 1976; 39(1):15-36. PubMed ID: 776116
[No Abstract] [Full Text] [Related]
17. Uremic neuropathy. Monitoring of transketolase activity inhibition in a child.
McVicar M; Gauthier B; Goodman CT
Am J Dis Child; 1973 Feb; 125(2):263-5. PubMed ID: 4265477
[No Abstract] [Full Text] [Related]
18. Experimental uremic neuropathy. Part 1. Decreased nerve conduction velocity in rats.
Tegnèr R; Brismar T
J Neurol Sci; 1984 Jul; 65(1):29-36. PubMed ID: 6470744
[TBL] [Abstract][Full Text] [Related]
19. Comparison of motor and sensory nerve conduction velocity in early uremic polyneuropathy.
Jebsen RH; Tenckhoff H
Arch Phys Med Rehabil; 1969 Mar; 50(3):124-6. PubMed ID: 4304421
[No Abstract] [Full Text] [Related]
20. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
